Methadone: a review of drug-drug and pathophysiological interactions.
Autor: | Kapur, Bhushan M., Hutson, Janine R., Chibber, Tamanna, Luk, Adriana, Selby, Peter |
---|---|
Předmět: |
ANTI-infective agents
ANTICONVULSANTS ANTIDEPRESSANTS BENZODIAZEPINES CARRIER proteins DISEASES DRUG interactions DRUGS of abuse GLYCOPROTEINS HEME INFORMATION storage & retrieval systems MEDICAL databases MACROLIDE antibiotics MEDLINE METHADONE hydrochloride NARCOTICS PHYSIOLOGY SEROTONIN uptake inhibitors TRANQUILIZING drugs SYSTEMATIC reviews PROTEASE inhibitors NUCLEOSIDE reverse transcriptase inhibitors REVERSE transcriptase inhibitors |
Zdroj: | Critical Reviews in Clinical Laboratory Sciences; Aug2011, Vol. 48 Issue 4, p171-195, 25p, 1 Chart |
Abstrakt: | Numerous established and potential drug interactions with methadone are clinically important in people treated with methadone either for addiction or for chronic pain. Methadone users often have comorbidities and are prescribed drugs that may interact with methadone. Methadone is extensively metabolized by cytochrome P450 (CYP) 3A4 and to a lesser extent by CYP 1A2, 2D6, 2D8, 2C9/2C8, 2C19, and 2B6. Eighty-six percent of methadone is protein bound, predominately to α |
Databáze: | Complementary Index |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |